Biotech-IgG AB Stock: price and insider trades · Sweden
Biotech-IgG AB: what insiders have been doing
Biotech-IgG AB is a listed company. Its insiders report their share dealings to Finansinspektionen. The past year has been quiet: not a single insider filing for Biotech-IgG AB. The previous disclosure was published on 5 July 2017.
Looking back to 2017, when coverage begins, insiders filed no purchases and 4 sales.
In the same market, recent insider purchases at Dynavox Group AB and Rusta AB (publ) also feature in our signals. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
- 630,237 shares@ SEK 0.15100.0% of flowISIN SE0002837955FI:csv-b18804804dafaab5cf2c
- 869,000 sharesISIN SE0002837955FI:csv-d2e155fedf2766b5a3fe
- 6,162,400 sharesISIN SE0002837955FI:csv-411897ff68863c83d3f9
- 500,000 shares@ SEK 47,856.00100.0% of flowISIN SE0002837955FI:csv-0fc9db8582dc3e6c0dc0
4 of 4 declarations
About Biotech-IgG AB
Biotech-IgG AB is a company focused on the development of biological therapies and diagnostics based on antibodies. It is listed on the Stockholm Stock Exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations